Close Menu
TechCentralTechCentral

    Subscribe to the newsletter

    Get the best South African technology news and analysis delivered to your e-mail inbox every morning.

    Facebook X (Twitter) YouTube LinkedIn
    WhatsApp Facebook X (Twitter) LinkedIn YouTube
    TechCentralTechCentral
    • News

      Blue Label Telecoms to change its name as restructuring gathers pace

      11 July 2025

      EFF vows to stop Starlink from launching in South Africa

      11 July 2025

      Get your ID delivered like pizza – home affairs’ latest digital shake-up

      11 July 2025

      Apple plans product blitz to reignite growth

      11 July 2025

      Nissan doubles down on South Africa despite plant uncertainty

      11 July 2025
    • World

      Grok 4 arrives with bold claims and fresh controversy

      10 July 2025

      Bitcoin pushes higher into record territory

      10 July 2025

      Cupertino vs Brussels: Apple challenges Big Tech crackdown

      7 July 2025

      Grammarly acquires e-mail start-up Superhuman

      1 July 2025

      Apple considers ditching its own AI in Siri overhaul

      1 July 2025
    • In-depth

      Siemens is battling Big Tech for AI supremacy in factories

      24 June 2025

      The algorithm will sing now: why musicians should be worried about AI

      20 June 2025

      Meta bets $72-billion on AI – and investors love it

      17 June 2025

      MultiChoice may unbundle SuperSport from DStv

      12 June 2025

      Grok promised bias-free chat. Then came the edits

      2 June 2025
    • TCS

      TCS+ | MVNX on the opportunities in South Africa’s booming MVNO market

      11 July 2025

      TCS | Connecting Saffas – Renier Lombard on The Lekker Network

      7 July 2025

      TechCentral Nexus S0E4: Takealot’s big Post Office jobs plan

      4 July 2025

      TCS | Tech, townships and tenacity: Spar’s plan to win with Spar2U

      3 July 2025

      TCS+ | First Distribution on the latest and greatest cloud technologies

      27 June 2025
    • Opinion

      In defence of equity alternatives for BEE

      30 June 2025

      E-commerce in ICT distribution: enabler or disruptor?

      30 June 2025

      South Africa pioneered drone laws a decade ago – now it must catch up

      17 June 2025

      AI and the future of ICT distribution

      16 June 2025

      Singapore soared – why can’t we? Lessons South Africa refuses to learn

      13 June 2025
    • Company Hubs
      • Africa Data Centres
      • AfriGIS
      • Altron Digital Business
      • Altron Document Solutions
      • Altron Group
      • Arctic Wolf
      • AvertITD
      • Braintree
      • CallMiner
      • CambriLearn
      • CYBER1 Solutions
      • Digicloud Africa
      • Digimune
      • Domains.co.za
      • ESET
      • Euphoria Telecom
      • Incredible Business
      • iONLINE
      • Iris Network Systems
      • LSD Open
      • NEC XON
      • Network Platforms
      • Next DLP
      • Ovations
      • Paracon
      • Paratus
      • Q-KON
      • SevenC
      • SkyWire
      • Solid8 Technologies
      • Telit Cinterion
      • Tenable
      • Vertiv
      • Videri Digital
      • Wipro
      • Workday
    • Sections
      • AI and machine learning
      • Banking
      • Broadcasting and Media
      • Cloud services
      • Contact centres and CX
      • Cryptocurrencies
      • Education and skills
      • Electronics and hardware
      • Energy and sustainability
      • Enterprise software
      • Fintech
      • Information security
      • Internet and connectivity
      • Internet of Things
      • Investment
      • IT services
      • Lifestyle
      • Motoring
      • Public sector
      • Retail and e-commerce
      • Science
      • SMEs and start-ups
      • Social media
      • Talent and leadership
      • Telecoms
    • Events
    • Advertise
    TechCentralTechCentral
    Home » World » Pfizer vaccine gets full approval from US regulators

    Pfizer vaccine gets full approval from US regulators

    By Agency Staff23 August 2021
    Twitter LinkedIn Facebook WhatsApp Email Telegram Copy Link
    News Alerts
    WhatsApp

    The Covid-19 vaccine made by Pfizer and BioNTech was granted a full approval by US regulators, a milestone expected to help bolster the immunisation drive.

    The Food and Drug Administration said in a statement on Monday that it had cleared the shot for the prevention of the disease caused by the novel coronavirus in people 16 and older. It will be marketed under the Comirnaty brandname. The approval is the first for a Covid vaccine.

    The two-dose regimen was initially made available in the US through an emergency authorisation late last year. It has since become the most widely used of three available vaccines against the disease caused by the coronavirus, according to data from the Centres for Disease Control and Prevention, with more than 92 million people having received two shots.

    The approval is likely to boost confidence in the shot among people who say they are wary of its rapid-fire development

    The approval is likely to boost confidence in the shot among people who say they are wary of its rapid-fire development, and could open the door to more vaccination requirements among employers and businesses.

    It is also likely to solidify the shot’s status as a blockbuster for its makers. Pfizer said last month it expects the vaccine to bring in US$33.5-billion in revenue this year, a total that would place it among the biggest-selling drugs of all time. In the second quarter, the vaccine booked $7.8-billion in sales.

    Shares rise

    Pfizer shares rose 3.7% at 10.14am in New York trading on Monday. BioNTech shares jumped 8.8%.

    Other vaccines could receive approvals in coming months. In June, Moderna said it had initiated a rolling submission of its Biologics Licence Application for its vaccine in people 18 and older.

    Pfizer and BioNTech approached the FDA in May with a so-called Biologics Licence Application or BLA, prompting even greater scrutiny of the two-shot regimen.

    “The FDA’s review of a BLA is among the most comprehensive in the world,” the agency said in an e-mail earlier this month. “We conduct our own analyses of the information in the BLA to make sure the vaccines are safe and effective and meet our standards for approval.”

    The companies’ submission was delivered in two batches. On 7 May, they shared a package of clinical data including more information on the vaccine’s effectiveness and six months of safety data — building on two months of safety data shared in the emergency-use application.

    Two weeks later, Pfizer and BioNTech shared information on the vaccine’s manufacturing processes and production facilities.

    Altogether, the application was 340 000 pages

    Altogether, the application was 340 000 pages, more than three times the length of the emergency authorisation submission. According to Pfizer, that’s significantly longer than the standard application package.

    Though the BLA review process typically takes eight months, US regulators said they turned to “sprint teams” to evaluate “a tremendous amount of data”. The review was ultimately concluded in less than half the time.  — Reported by Riley Griffin, (c) 2021 Bloomberg LP



    BioNTech Moderna Pfizer
    Subscribe to TechCentral Subscribe to TechCentral
    Share. Facebook Twitter LinkedIn WhatsApp Telegram Email Copy Link
    Previous ArticleWhere unicorns roam wild
    Next Article Ethiopia to build local rival to Facebook and WhatsApp

    Related Posts

    SA may have to destroy 100 000 Covid vaccine doses

    4 March 2022

    New Covid vaccination rules in South Africa – what you need to know

    21 February 2022

    Pfizer vaccine offers partial Omicron protection: study

    8 December 2021
    Company News

    $125-trillion traded: Binance redefines global finance in just eight years

    11 July 2025

    LTE Cat 1 vs Cat 1 bis – what’s the difference?

    11 July 2025

    NEC XON welcomes HPE acquisition of Juniper Networks

    11 July 2025
    Opinion

    In defence of equity alternatives for BEE

    30 June 2025

    E-commerce in ICT distribution: enabler or disruptor?

    30 June 2025

    South Africa pioneered drone laws a decade ago – now it must catch up

    17 June 2025

    Subscribe to Updates

    Get the best South African technology news and analysis delivered to your e-mail inbox every morning.

    © 2009 - 2025 NewsCentral Media

    Type above and press Enter to search. Press Esc to cancel.